Abstract
Context: In this manuscript, a high-performance liquid chromatography (HPLC) method for the determination of metronidazole in pharmaceuticals was described and developed. Methods: The reversed-phase HPLC (RP-HPLC) method was developed and the results obtained to determine the form of metronidazole. Chromatographic analysis was performed in HPLC-ultraviolet (HPLC-UV) system with Ion Pac column; Arcus EP-C18; 5 μm, 4.6 mm× 250 mm, with acetonitrile: triethylamine 30:70 (v/v)+0.5 M potassium dihydrogen orthophosphate buffer at pH 4.5 as mobile phase, at a flow rate of 1.0 ml/min. UV detection in HPLC system was performed at 310 nm. Results: The method was validated for accuracy, precision, specificity, linearity, and sensitivity. The retention time for the metronidazole was 9.9 min. Calibration plots were linear over the concentration ranges 1–5 μg/L for the metronidazole. The limit of detection was 0.115 μg/ml and the limit of quantitation was 0.437 μg/ml. The accuracy of the proposed method was determined by recovery studies and found to be from 93.3% to 100%. Conclusion: Commercial tablet formulation was successfully analyzed using the developed HPLC-UV method that has been validated; accuracy, precision, and specificity were found to be within the acceptable limits. Moreover, results obtained by the suggested methods showed no significant difference between the results obtained from the suggested method.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.